$EOLS Cashflow Statement | Understand Stock

$EOLS

$7.37 +$0.20 (2.79%) Close

$EOLS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Provision for bad debts
Amortization of discount on short-term investments
Provision for credit losses and inventory
Amortization of operating lease right-of-use assets
Amortization of debt discount and issuance costs
Paid-in-kind interest on convertible note
Deferred income taxes
Revaluation of contingent royalty obligation payable to Evolus Founders
Loss from extinguishment of debts, net
Non-cash portion of accrued settlement expenses
Non-cash in-process research and development expense
Other adjustments to operating activities
Changes in operating assets and liabilities:
Inventories
Accounts receivable
Prepaid expenses and other current assets
Prepaid expenses
Other assets
Accounts payable
Accrued expenses
Accrued litigation settlement
Operating lease liabilities
Other operating assets

Net cash used in operating activities
Cash flows from investing activities
Purchases of property and equipment
Additions to capitalized software
Purchases of short-term investments
Maturities of short-term investments
Net cash used in investing activities

Cash flows from financing activities
Repayment of long term debt
Repayment of promissory note payable to Evolus Founders
Payment of contingent royalty obligation to Evolus Founders
Proceeds from issuance of convertible note
Payment for debt obligation
Proceeds from issuance and modification of debt instruments
Payments for debt modification fees and debt issuance costs
Proceeds from follow-on offering
Follow-on Offering
ATM Sales Agreement
Total proceeds from follow-on offering

Payments for offering costs
Issuance of common stock in connection with incentive equity plan
Payment of finance lease obligations
Tax withholding paid on behalf of employees for net share settlement
Net cash provided by financing activities

Effect of exchange rates on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income taxes
Conversion of convertible note to equity
Issuance of common stock in exchange for litigation settlement expense
Non-cash investing and financing information
Operating lease right-of-use assets obtained in exchange for operating lease liabilities
Capital expenditures included in accounts payable and accrued expenses
Issuance of common stock in connection with Symatese Europe Agreement

Comments